Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06374238 · ClinicalTrials.gov registry record · NA

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

A NA study of Pain and Sickle Cell Disease, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
470
Enrollment target
14
Study locations

NCT06374238: Recruiting NA study of Pain and Sickle Cell Disease, sponsored by University of Pittsburgh.

NCT06374238 is a NA study of Pain and Sickle Cell Disease that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 470 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (55% higher). The trial reports 14 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06374238, a NA study of Pain and Sickle Cell Disease, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
470 participants
Enrollment target
14
Study locations

Study Summary

The study, known as the Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy (PRESENCE), aims to determine the effectiveness of digital CBT in reducing pain, opioid use, and healthcare utilization among AYAs with SCD. It also seeks to understand the role of personalized peer support in enhancing engagement and outcomes of digital CBT interventions. By leveraging existing infrastructure for delivering virtual peer support interventions, tailored digital CBT programs for individuals with SCD, and partnerships with CBOs, the study aims to provide valuable insights into the feasibility and effectiveness of digital CBT as a pain management strategy for this vulnerable population.

Primary Outcome

Mean change in pain intensity as measured by the Pain, Enjoyment of Life and General Activity (PEG-3) scale. Item 1 asks individuals to rate their pain, on average, over the past week, using a 0-10 rating scale.

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL CBT+ Health coach
  • BEHAVIORAL CBT w/o Health Coach ( self-guided)

Study Locations (14)

New York

  • Weil Cornell Medical College - New York
  • University of Rochester Medical Center - Rochester

North Carolina

  • Wake Forest Baptist Hospital - Durham
  • East Carolina University Health Medical Center - Greenville

Pennsylvania

  • UPMC University of Pittsburgh Classical Hematology Adult Clinic - Pittsburgh
  • UPMC Children's Hospital of Pittsburgh - Pittsburgh

Alabama

  • University of South Alabama Medical Center - Mobile

California

  • UCLA Mattel Children's Hospital Ronald Reagan Hospital - Los Angeles

Connecticut

  • Connecticut Children's Medical Center - Hartford

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Illinois

  • Ann and Robert H. Lurie Children's Hospital of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 470 participants
Start Date 2025-03-10
Est. Completion 2028-05
Phase NA
University of Pittsburgh

1,238 total trials

What NCT06374238 shows while recruiting

NCT06374238 is an interventional study that assigns participants to a tested intervention. The registered 470 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (55% higher).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.

NCT06374238 lists 14 locations in 11 states (New York, North Carolina, Pennsylvania).

Frequently Asked Questions

What is clinical trial NCT06374238 about?

NCT06374238 is a clinical study titled "Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain". The study, known as the Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy (PRESENCE), aims to determine the effectiveness of digital CBT in reducing pain, opioid use, and healthcare utilization among AYAs with SCD. It also se...

What is the current status of trial NCT06374238?

This trial is currently recruiting. It is a NA study. The enrollment target is 470 participants. The study started on 2025-03-10. Estimated completion is 2028-05.

What conditions does trial NCT06374238 study?

This clinical trial studies the following conditions: Pain, Sickle Cell Disease.

What interventions are being tested in trial NCT06374238?

The interventions under investigation include: Usual Care (BEHAVIORAL), CBT+ Health coach (BEHAVIORAL), CBT w/o Health Coach ( self-guided) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06374238?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06374238 being conducted?

This trial has 14 study locations across Alabama, California, Connecticut, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06374238's enrollment target sits among peer trials

470 37th of 374 higher than 338 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05256940 · 470 participants · NA

    Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide

  • NCT05458219 · 470 participants · Phase 1

    A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

  • NCT05850689 · 470 participants · Phase 3

    Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  • NCT05935384 · 470 participants

    SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06374238, the US trial registry maintained by the National Library of Medicine. NCT06374238 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.